These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
98 related articles for article (PubMed ID: 10446639)
1. The latest weapon in the war against cancer. Wakeling KS RN; 1999 Jul; 62(7):58-60; quiz 63. PubMed ID: 10446639 [No Abstract] [Full Text] [Related]
3. [Adoptive immunotherapy in solid tumors: new hope]. Jotereau F; Labarrière N; Gervois N; Pandolfino MC; Dreno B Med Sci (Paris); 2003 Mar; 19(3):268-70. PubMed ID: 12836404 [No Abstract] [Full Text] [Related]
4. Adoptive cellular immunotherapy for childhood malignancies. Cooper LJ Bone Marrow Transplant; 2008 Jan; 41(2):183-92. PubMed ID: 18026145 [TBL] [Abstract][Full Text] [Related]
5. Natural killer cells in cancer. Höglund P; Klein E Semin Cancer Biol; 2006 Oct; 16(5):331-2. PubMed ID: 16931040 [No Abstract] [Full Text] [Related]
6. Dendritic cells: a journey from laboratory to clinic. Cerundolo V; Hermans IF; Salio M Nat Immunol; 2004 Jan; 5(1):7-10. PubMed ID: 14699398 [No Abstract] [Full Text] [Related]
7. [Application of gene therapy in tumor adoptive immunotherapy]. Wang C; Zhao Y Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2008 Apr; 25(2):482-6. PubMed ID: 18610648 [TBL] [Abstract][Full Text] [Related]
8. Antigen choice in adoptive T-cell therapy of cancer. Offringa R Curr Opin Immunol; 2009 Apr; 21(2):190-9. PubMed ID: 19297140 [TBL] [Abstract][Full Text] [Related]
9. Immuno-cell therapy of cancer in Japan. Egawa K Anticancer Res; 2004; 24(5C):3321-6. PubMed ID: 15515427 [TBL] [Abstract][Full Text] [Related]
10. Adenovirus as vehicle for anticancer genetic immunotherapy. Gallo P; Dharmapuri S; Cipriani B; Monaci P Gene Ther; 2005 Oct; 12 Suppl 1():S84-91. PubMed ID: 16231059 [TBL] [Abstract][Full Text] [Related]
11. GMP production of anti-tumor cytotoxic T-cell lines for adoptive T-cell therapy in patients with solid neoplasia. Turin I; Pedrazzoli P; Tullio C; Montini E; La Grotteria MC; Schiavo R; Perotti C; Locatelli F; Carretto E; Maccario R; Siena S; Montagna D Cytotherapy; 2007; 9(5):499-507. PubMed ID: 17786611 [TBL] [Abstract][Full Text] [Related]
12. T cells take aim at cancer. Pardoll D Proc Natl Acad Sci U S A; 2002 Dec; 99(25):15840-2. PubMed ID: 12461164 [No Abstract] [Full Text] [Related]
13. [Antitumor cellular immunotherapy: the breakthrough of dendritic cells]. Angevin E; André F; Zitvogel L Bull Cancer; 2000 Jan; 87(1):107-15. PubMed ID: 10673639 [No Abstract] [Full Text] [Related]
14. Regulators of apoptosis: suitable targets for immune therapy of cancer. Andersen MH; Becker JC; Straten Pt Nat Rev Drug Discov; 2005 May; 4(5):399-409. PubMed ID: 15864269 [TBL] [Abstract][Full Text] [Related]
15. Adoptive T-cell therapy of cancer. Yee C Hematol Oncol Clin North Am; 2006 Jun; 20(3):711-33. PubMed ID: 16762731 [TBL] [Abstract][Full Text] [Related]
16. Genetically engineered T cells as adoptive immunotherapy of cancer. Ma Q; Gonzalo-Daganzo RM; Junghans RP Cancer Chemother Biol Response Modif; 2002; 20():315-41. PubMed ID: 12703212 [No Abstract] [Full Text] [Related]
17. Adoptive cellular immunotherapy of cancer: a three-signal paradigm for translating recent developments into improved treatment strategies. Jensen SM; Fox BA Cancer Treat Res; 2005; 123():293-336. PubMed ID: 16211876 [No Abstract] [Full Text] [Related]